阿凯迪亚生物科学 2025年度报告

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.YES†NO_Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.YES†NO_ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during thepreceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90days.YES_NO† Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).YES_NO† Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerginggrowth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 ofthe Exchange Act. Large accelerated filerտNon-accelerated filerցEmerging growth companyտ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revisedfinancial accounting standards provided pursuant to Section 13(a) of the Exchange Act.տ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control overfinancial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.† If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect thecorrection of an error to previously issued financial statements.տIndicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).տ Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).YES†NO_ The aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant as of June 30, 2025, the last business day of theRegistrant’s most recently completed second fiscal quarter, was approximately $5,740,919 (based on the closing price of $4.31 on June 30, 2025 on the NASDAQCapital Market).$0.001 par value per share. DOCUMENTS INCORPORATED BY REFERENCE Information required by Part III of this Annual Report on Form 10-K is incorporated by reference to portions of the Registrant's Definitive Proxy Statement for its 2026Annual Meeting of Stockholders, which the registrant intends to file with the Securities and Exchange Commission within 120 days after the end of the fiscal yearcovered by this Form 10-K. INTRODUCTION “Arcadia,” the “Company,” "management," “we,” “our” and “us” are used interchangeably to refer to Arcadia Biosciences, Inc. and itssubsidiaries. SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K contains forward-looking statements within the meaning of the federal securities laws, whichstatements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events, our futurefinancial or operating performance, growth strategies, anticipated trends in our industry, and our potential opportunities, plans, andobjectives. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should,""expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts,""potential," or "continue" or the negative of these words or other similar terms or expressions that concern our expectations, strategy,plans, or intentions. Forward-looking statements contained in this Annual Report on Form 10-K include, but are not limited to,statements about: •our ability to earn revenues from the sale of products;•market conditions for products, including competitive factors and the supply and pricing of competing products;•compliance with laws and regulations that impact our business, and changes to such laws and regulations;•our ability to maintain, protect, and enhance our intellectual property;•our future capital requirements and our ability to satisfy our capital needs;•industry conditions and market conditions;•the preceding and other factors discussed in Part I, Item 1A, “Risk Factors,” and